Home
Institutions
Filings
Issuers
About
All
Index / Passive
Hedge Fund
VC / PE / Holdco
Long-Term Concentrated
Concentrated Active
Quant / Systematic
Diversified Active
PROVECTUS BIOPHARMACEUTICALS
CUSIP: 74373P116
Class: *W EXP 06/24/202
Holders for Q4 2025
Position Changes for Q4 2025
Note: Option positions (PUT/CALL) are excluded.
No position changes found for this quarter